Does RISANKIZUMAB-RZAA Cause Drug hypersensitivity? 247 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Drug hypersensitivity have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
247
Reports of Drug hypersensitivity with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
2
Deaths
85
Hospitalizations
How Dangerous Is Drug hypersensitivity From RISANKIZUMAB-RZAA?
Of the 247 reports, 2 (0.8%) resulted in death, 85 (34.4%) required hospitalization, and 6 (2.4%) were considered life-threatening.
Is Drug hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 247 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Drug hypersensitivity?
METHOTREXATE (16,677)
ETANERCEPT (12,991)
ADALIMUMAB (11,599)
MORPHINE (11,095)
RITUXIMAB (8,924)
LEFLUNOMIDE (8,148)
INFLIXIMAB (8,119)
TOCILIZUMAB (7,883)
ABATACEPT (7,808)
CODEINE (7,479)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Drug hypersensitivity Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA